Table 2. Distribution of clinical variables and the proportion of cognitive impairment among the study participants.
| Variable | Frequency (n=240) (%) | Cognitive impairment | ||||
| Mild (n=40) | Moderate (n=31) | Severe (n=01) | Total (n=72) (%) | |||
| Duration of illness | < 5 years | 113 (47.1) | 18 | 15 | - | 33 (45.8) |
| 5-9 years | 64 (26.6) | 10 | 12 | - | 22 (30.6) | |
| ≥ 10 years | 63 (26.3) | 12 | 4 | 01 | 17 (23.6) | |
| Co-morbidity | Present | 153 (63.8) | 26 | 24 | - | 50 (69.4) |
| Absent | 87 (36.2) | 14 | 07 | 01 | 22 (30.6) | |
| Treatment | Oral Hypoglycemic Agents | 217 (90.4) | 33 | 30 | - | 63 (87.5) |
| Insulin | 06 (2.5) | 04 | - | 01 | 05 (6.9) | |
| Both | 17 (7.1) | 03 | 01 | - | 04 (5.6) | |
| Probable symptomatic hypoglycemia | Present | 95 (39.6) | 20 | 18 | 01 | 39 (54.2) |
| Absent | 145 (60.4) | 20 | 13 | - | 33 (45.8) | |
| Blood sugar | Under control | 109 (45.4) | 18 | 13 | 01 | 32 (44.4) |
| Uncontrolled | 131 (54.6) | 22 | 18 | - | 40 (55.6) | |
| Exercise | Adequate | 59 (24.6) | 12 | 04 | - | 16 (22.2) |
| Inadequate | 181 (75.4) | 28 | 27 | 01 | 56 (77.8) | |
| Body mass index | < 18.5 | 08 (3.3) | 01 | 05 | 01 | 07 (9.7) |
| 18.5-22.9 | 66 (27.5) | 14 | 04 | - | 18 (25.0) | |
| 23-24.9 | 50 (20.8) | 10 | 06 | - | 16 (22.2) | |
| 25-29.9 | 83 (34.6) | 11 | 14 | - | 25 (34.8) | |
| ≥ 30 | 33 (13.8) | 04 | 02 | - | 06 (8.3) | |